{
    "organizations": [],
    "uuid": "894e00c75299b397c30feb223d5e0977a90d7dbc",
    "author": "",
    "url": "https://www.reuters.com/article/brief-avadel-pharma-receives-orphan-drug/brief-avadel-pharma-receives-orphan-drug-designation-from-fda-for-ft-218-idUSASB0C0IG",
    "ord_in_thread": 0,
    "title": "BRIEF-Avadel Pharma Receives Orphan Drug Designation From FDA For FT 218",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 36 PM / Updated 9 minutes ago BRIEF-Avadel Pharma Receives Orphan Drug Designation From FDA For FT 218 Reuters Staff 1 Min Read \nJan 10 (Reuters) - Avadel Pharmaceuticals Plc: \n* AVADEL PHARMACEUTICALS RECEIVES ORPHAN DRUG DESIGNATION FROM FDA FOR FT 218 FOR THE TREATMENT OF NARCOLEPSY Source text for Eikon: Further company coverage:",
    "published": "2018-01-10T14:34:00.000+02:00",
    "crawled": "2018-01-10T14:51:57.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "pharma",
        "receives",
        "orphan",
        "drug",
        "designation",
        "fda",
        "ft",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "avadel",
        "pharmaceutical",
        "plc",
        "avadel",
        "pharmaceutical",
        "receives",
        "orphan",
        "drug",
        "designation",
        "fda",
        "ft",
        "treatment",
        "narcolepsy",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}